Biogen (BIIB) had the highest return between September 30, 1995 and January 1, 1996 by a large-cap US stock, returning 147.6%.
| ASSET | DATE | % RETURN |
|---|---|---|
Biogen (BIIB) | 9/30/1995 - 1/1/1996 | 147.62% |
NetApp (NTAP) | 9/30/1995 - 1/1/1996 | 95.73% |
Hologic (HOLX) | 9/30/1995 - 1/1/1996 | 78.26% |
Intuit (INTU) | 9/30/1995 - 1/1/1996 | 65.96% |
TJX Companies (TJX) | 9/30/1995 - 1/1/1996 | 60.5% |
Cadence Design Systems (CDNS) | 9/30/1995 - 1/1/1996 | 58.49% |
Gilead Sciences (GILD) | 9/30/1995 - 1/1/1996 | 45.47% |
Gartner (IT) | 9/30/1995 - 1/1/1996 | 43.98% |
Vertex Pharmaceuticals (VRTX) | 9/30/1995 - 1/1/1996 | 42.28% |
Humana (HUM) | 9/30/1995 - 1/1/1996 | 36.02% |
UnitedHealth (UNH) | 9/30/1995 - 1/1/1996 | 35.14% |
Telkom Indonesia (Persero) Tbk PT ADR Rep 100 B (TLK) | 9/30/1995 - 1/1/1996 | 32.89% |
Deere (DE) | 9/30/1995 - 1/1/1996 | 30.7% |
Universal Health Services (UHS) | 9/30/1995 - 1/1/1996 | 30.03% |
Applied Industrial Technologies (AIT) | 9/30/1995 - 1/1/1996 | 29.74% |
MasTec (MTZ) | 9/30/1995 - 1/1/1996 | 29.27% |
Renaissancere (RNR) | 9/30/1995 - 1/1/1996 | 28.98% |
Zebra Technologies (ZBRA) | 9/30/1995 - 1/1/1996 | 28.91% |
Fifth Third Bancorp (FITB) | 9/30/1995 - 1/1/1996 | 28.64% |
Erie Indemnity (ERIE) | 9/30/1995 - 1/1/1996 | 28.55% |
Nucor (NUE) | 9/30/1995 - 1/1/1996 | 27.82% |
Teva Pharma Industries Ltd ADR (TEVA) | 9/30/1995 - 1/1/1996 | 27.65% |
LIN TV (LIN) | 9/30/1995 - 1/1/1996 | 27.24% |
Eli Lilly and (LLY) | 9/30/1995 - 1/1/1996 | 26.94% |
CoreSite Realty (COR) | 9/30/1995 - 1/1/1996 | 26.92% |
Large-cap stocks are treated as having a market cap of $10B+.
